iRhythm Holdings, Inc.
IRTCHealthcareNASDAQMedical Devices · Last scanned Jul 16, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, iRhythm Holdings, Inc. focuses on Medical Devices services and products. iRhythm Holdings, Inc. iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to. With a market capitalization of $3.72B, it sits in mid-cap territory. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.
Market Cap
$3.72B
Beta
1.27
P/E (TTM)
—
P/E (Fwd)
106.69
EPS (TTM)
$-0.86
EPS (Fwd)
$1.06
ROE
-22.4%
ROA
-1.1%
Cash
$549.6M
Total Debt
$729.3M
Free CF
$57.0M
52W Change
-17.3%
Annual Financials
Cash vs Debt
The company holds $549.6M in cash, though total debt stands at $729.3M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $57.0M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -22.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $410.9M (2022) to $747.1M (2025), reflecting a 82% increase over the period.
As with any equity investment, IRTC carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence iRhythm Holdings, Inc.'s trajectory.